Lippincott Pharmacology Practice Exam

The recommendation to use sunscreen and avoid excessive UV exposure is crucial in preventing phototoxicity when using fluoroquinolone therapy. Fluoroquinolones, a class of antibiotics, have been associated with increased sensitivity to sunlight, which can lead to adverse skin reactions when patients are exposed to ultraviolet (UV) light. This heightened sensitivity may manifest as rashes, burns, or other dermatological reactions.

By advising patients to apply sunscreen, particularly one with a high SPF, they can create a protective barrier against harmful UV rays, significantly reducing the chances of experiencing these solarium-induced side effects. Additionally, recommending that patients minimize sun exposure, particularly during peak UV radiation hours, contributes to preventing phototoxic reactions.

Other options, while important in their respective contexts, do not provide direct benefits for managing or preventing phototoxicity. Taking the medication at night does not address the issue of UV exposure during the day. Taking it with food may enhance absorption or reduce gastrointestinal side effects but has no effect on phototoxicity. Drinking 1 liter of water daily is sensible for hydration but is unrelated to preventing reactions to sunlight. Therefore, the correct recommendation focuses on sun protection strategies to mitigate the risk of phototoxicity with fluoroquinolone therapy.